{
    "id": 28009,
    "fullName": "ESR1 - SOX9",
    "impact": "fusion",
    "proteinEffect": "gain of function - predicted",
    "geneVariantDescriptions": [
        {
            "description": "ESR1-SOX9 results from the fusion of ESR1 and SOX9, resulting in activity independent of ligand and hyperactivity that is forty times greater than wild-type Esr1 basal activity (PMID: 29360925). ESR1-SOX9 has been identified in ER-positive, HER2 (ERBB2)-positive breast cancer (PMID: 29360925).",
            "references": [
                {
                    "id": 11301,
                    "pubMedId": 29360925,
                    "title": "Recurrent hyperactive ESR1 fusion proteins in endocrine therapy-resistant breast cancer.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/29360925"
                }
            ]
        }
    ],
    "type": null,
    "gene": {
        "id": 2099,
        "geneSymbol": "ESR1",
        "terms": [
            "ESR1",
            "ER",
            "Era",
            "ESR",
            "ESRA",
            "ESTRR",
            "NR3A1"
        ]
    },
    "variant": "ESR1 - SOX9",
    "createDate": "05/01/2018",
    "updateDate": "05/01/2018",
    "referenceTranscriptCoordinates": null,
    "partnerGenes": [
        {
            "gene": {
                "id": 6662,
                "geneSymbol": "SOX9",
                "terms": [
                    "SOX9",
                    "CMD1",
                    "CMPD1",
                    "SRA1",
                    "SRXX2",
                    "SRXY10"
                ]
            }
        }
    ],
    "evidence": [
        
    ],
    "molecularProfiles": [
        {
            "id": 29582,
            "profileName": "ESR1 - SOX9",
            "profileTreatmentApproaches": [
                
            ]
        }
    ],
    "allTranscriptCoordinates": [
        
    ]
}